Holding a stock versus buying more: why the questions differ

Start from the same current evidence#

Read the latest company results, material disclosures and financial position. Your earlier research may still be useful, but it is not permanently valid. Check whether customer demand, profitability, cash needs and share count have changed.

Keep your original thesis as a dated record. Add a current assessment instead of editing the old note until it appears to have predicted every development. The losing-stock review shows this process when the evidence is uncomfortable.

Understand the incremental exposure#

Suppose a fictional portfolio worth $100,000 includes $10,000 in one company. Moving $5,000 from cash within that portfolio into the same stock increases its weight from 10% to 15%, before costs and market movements.

If instead you contribute $5,000 of new money and invest it all in the stock, the position becomes $15,000 in a $105,000 portfolio, approximately 14.286%. The source of the money changes the arithmetic.

Neither weight is presented as suitable. The example shows why “I still like the company” does not describe the whole effect of adding. Shared exposures elsewhere in the portfolio also matter.

Separate conviction from position size#

You may understand a business well and still be unable to bear a large loss in it. Confidence in an explanation does not remove uncertainty about customers, financing, competition or valuation.

Conversely, deciding not to add does not necessarily mean the original thesis is broken. You may already have substantial exposure, need liquidity or prefer to investigate other opportunities. Those are different reasons and should be recorded honestly.

Consider costs and constraints without making them the thesis#

Selling can have tax and transaction consequences; adding uses available capital. The relevance of each depends on jurisdiction, account type and circumstances. Get appropriate advice for those specifics.

A potential tax bill does not improve a company's economics. A low dealing fee does not make another purchase attractive. Keep those practical costs beside the business case rather than allowing them to replace it.

Compare with the alternatives available now#

The relevant alternative may be another researched investment, maintaining liquidity or waiting for information. It is not necessarily the stock you wish you had bought years ago.

Ask what additional uncertainty the new money would bear and what expected business outcome supports taking it. If you cannot explain the current valuation, revisit the valuation guide before treating familiarity as an advantage.

Write two separate conclusions#

One note can describe whether the current evidence still supports your business thesis. Another can describe the effect of changing exposure. Keeping them separate prevents a portfolio constraint from masquerading as a company problem, or a good company story from deciding position size for you.

This process is educational. It cannot determine whether you should buy, hold or sell a security or how much money you should allocate.